Responses
Abstracts
General and Risk Management, Patient Safety (including: medication errors, quality control)
Evaluation of the efficacy and safety of romiplostim in idiopathic thrombocytopenic purpura: a case report
Compose a Response to This Article
Other responses
No responses have been published for this article.